FGF14 and lung carcinoma: The results of CCK-8 and EdU assays showed that after inhibiting the expression of FGF14 in lung cancer cells, the proliferation rate of tumor cells significantly increased (Fig. 4C, D), and the wound healing assay results demonstrated that the migration ability of lung cancer cells was enhanced (Fig. 4E).